Main Library
In this 2026 measurement year, CMS’s sociodemographic status (SDS) risk adjustment is changing how medication adherence is measured, who you need to focus on, and why it matters more than ever.
One in eight Medicare beneficiaries qualifies through disability rather than age, and this population underperforms across all three adherence measures by 3% or more. Yet, under the new SDS framework, this population is precisely where one of your biggest performance opportunities lives.
In this executive briefing, we’ll decode what the data reveals about disabled and LIS/DE member populations, why conventional adherence programs miss them entirely, and how one health plan turned this gap into measurable gains. You’ll leave with a clear framework for building the infrastructure you need now, before 1x weighting gives way to triple weight in 2027.
What attendees will learn:
· How CMS’s SDS risk-adjustment equation works
· Why disabled beneficiaries underperform even dual-eligible and LIS populations and what is driving that gap
· How one health plan identified and closed the gap on LIS, Duals, and disabled high-risk members disability adherence gap using real-time data and specialized care teams
· What outreach and care coordination must look like for members with cognitive, physical, and behavioral barriers
· Why strong 2026 performance is the critical setup for 2027’s return to triple weighting